# Transfemoral Transcatheter Aortic Valve Implementation at Hospital Without On-site Cardiac Surgery: Early Clinical Outcome in Patients With Prohibitive Surgical Risk.

Study · id `cardio:ct-nct05886517` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05886517](<https://clinicaltrials.gov/study/NCT05886517>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05886517

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.

## Technical summary

Registry record NCT05886517. Allocation not applicable; no masking; primary purpose treatment. Start 2023-05-01 (actual); primary completion 2026-03 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT05886517, source copy `cardio:ctgov-nct05886517-2025-02-21`, retrieved 2026-10-26)
- Started: 2023-05-01 (actual) (ClinicalTrials.gov record NCT05886517, source copy `cardio:ctgov-nct05886517-2025-02-21`, retrieved 2026-10-26)
- Primary completion: 2026-03 (anticipated) (ClinicalTrials.gov record NCT05886517, source copy `cardio:ctgov-nct05886517-2025-02-21`, retrieved 2026-10-26)
- Completion: 2026-04 (anticipated) (ClinicalTrials.gov record NCT05886517, source copy `cardio:ctgov-nct05886517-2025-02-21`, retrieved 2026-10-26)
- Countries: Italy; Spain (ClinicalTrials.gov record NCT05886517, source copy `cardio:ctgov-nct05886517-2025-02-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05886517-2025-02-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Transfemoral Transcatheter Aortic Valve Implementation at Hospital Without On-site Cardiac Surgery: Early Clinical Outcome in Patients With Prohibitive Surgical Risk.
- Condition: Aortic Stenosis
- Intervention (Device): Transfemoral transcatheter aortic valve implementation
- Lead sponsor: AUSL Romagna Rimini
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)

## Provenance

Content hash: a8d1822f745c9540bcd4f4bd87b1908e6f697260898d1db5e67c78a7ae2d16fb
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
